Relief Therapeutics Holding AG (RLF) — Cash Flow Reinvestment Rate
Relief Therapeutics Holding AG (RLF) has a Cash Flow Reinvestment Rate of 0.04x as of December 2024, reinvesting CHF14.00K (capex CHF14.00K ) from operating cash flow of CHF359.00K. Explore Relief Therapeutics Holding AG capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Relief Therapeutics Holding AG Cash Flow Reinvestment Rate (2006–2006)
Historical reinvestment intensity for Relief Therapeutics Holding AG across 1 annual periods. Also explore Relief Therapeutics Holding AG assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Relief Therapeutics Holding AG (2006–2006)
Year-by-year capital reinvestment analysis for Relief Therapeutics Holding AG. For live market cap and broader valuation context, see market cap of Relief Therapeutics Holding AG.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2006 | 0.21x | CHF474.60K | CHF2.28 Million | CHF474.60K | — |